scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M311000200 |
P8608 | Fatcat ID | release_2fy5rslelzdp3j6irxwkoufwhi |
P3181 | OpenCitations bibliographic resource ID | 375385 |
P698 | PubMed publication ID | 14668353 |
P2093 | author name string | Robert V. Farese | |
Scot J. Stone | |||
Peter M. Elias | |||
Steven M. Watkins | |||
Barbara E. Brown | |||
Kenneth R. Feingold | |||
Heather M. Myers | |||
P2860 | cites work | Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members | Q24291503 |
A novel diacylglycerol acyltransferase (DGAT2) is decreased in human psoriatic skin and increased in diabetic mice | Q24296647 | ||
Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase | Q24530606 | ||
Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes | Q24563247 | ||
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis | Q24645996 | ||
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
Synthesis of triacylglycerols by the acyl-coenzyme A:diacyl-glycerol acyltransferase Dga1p in lipid particles of the yeast Saccharomyces cerevisiae | Q27933343 | ||
MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine | Q28585013 | ||
Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2 | Q28587595 | ||
An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination | Q29615355 | ||
The DGA1 gene determines a second triglyceride synthetic pathway in yeast. | Q30667251 | ||
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat | Q33901239 | ||
Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption | Q34181429 | ||
Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation | Q34205361 | ||
Human intestinal monoacylglycerol acyltransferase: differential features in tissue expression and activity | Q34208422 | ||
Enzymes of Glycerolipid Synthesis in Eukaryotes | Q34251809 | ||
Impaired Energy Homeostasis in C/EBPα Knockout Mice | Q34662358 | ||
Fetal programming of the growth hormone-insulin-like growth factor axis. | Q34942769 | ||
Lipoapoptosis: its mechanism and its diseases | Q35047180 | ||
Life without white fat: a transgenic mouse | Q35210661 | ||
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy | Q35210714 | ||
Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. | Q36212658 | ||
Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models | Q38364107 | ||
Properties of the mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2. | Q40590382 | ||
Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover | Q43555581 | ||
Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or alpha-linolenic acids | Q43598211 | ||
Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue | Q43638421 | ||
Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction | Q44030446 | ||
Storage lipid synthesis is non-essential in yeast. | Q52544739 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Diacylglycerol O-acyltransferase 2 | Q21982898 |
Diacylglycerol O-acyltransferase 1 | Q21982901 | ||
P304 | page(s) | 11767–11776 | |
P577 | publication date | 2004-03-19 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Lipopenia and skin barrier abnormalities in DGAT2-deficient mice | |
P478 | volume | 279 |
Q37305365 | 1-O-acylceramides are natural components of human and mouse epidermis |
Q35131341 | 6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism |
Q36080184 | A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics |
Q59125135 | A Discussion on the Relationship between Skin Lipid Metabolism and Whole-Body Glucose and Lipid Metabolism: Systematic Review |
Q55669624 | A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis. |
Q55235061 | A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis. |
Q42857969 | A fluorescent assay to quantitatively measure in vitro acyl CoA:diacylglycerol acyltransferase activity |
Q28118294 | A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters |
Q90719687 | A novel role for DGATs in cancer |
Q34461158 | A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration |
Q47744240 | A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis |
Q37136747 | Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice |
Q36029131 | Acyl-CoA:Diacylglycerol Acyltransferase 1 Expression Level in the Hematopoietic Compartment Impacts Inflammation in the Vascular Plaques of Atherosclerotic Mice |
Q38282398 | Acyltransferase inhibitors: a patent review (2010-present). |
Q35819382 | Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling |
Q37604291 | Adipocytes in skin health and disease |
Q28504549 | Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity |
Q38323956 | Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice |
Q42824486 | Apolipoprotein B and triacylglycerol secretion in human triacylglycerol hydrolase transgenic mice |
Q59327080 | Arabidopsis thaliana DGAT3 is a [2Fe-2S] protein involved in TAG biosynthesis |
Q50062152 | Association of DGAT2 gene polymorphisms with carcass and meat quality traits in domestic pigeons (Columba livia). |
Q43784166 | AtDGAT2 is a functional acyl-CoA:diacylglycerol acyltransferase and displays different acyl-CoA substrate preferences than AtDGAT1. |
Q37076454 | Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism |
Q52675140 | Catalytic properties of MGAT3, a putative triacylgycerol synthase. |
Q47951459 | Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets |
Q38179801 | Chemical modulation of glycerolipid signaling and metabolic pathways |
Q44598904 | Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats. |
Q52571243 | Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. |
Q64267651 | Complete Inactivation of Sebum-Producing Genes Parallels the Loss of Sebaceous Glands in Cetacea |
Q35994369 | Compromised epidermal barrier stimulates Harderian gland activity and hypertrophy in ACBP-/- mice |
Q41260707 | Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation |
Q38763876 | Control of chylomicron export from the intestine |
Q28506881 | Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes |
Q46654994 | Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism |
Q48678334 | Cytosolic lipolysis and lipophagy: two sides of the same coin |
Q36074560 | DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling |
Q28585713 | DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes |
Q37479311 | DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity |
Q98184358 | DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis |
Q43184237 | DGAT1, DGAT2 and PDAT expression in seeds and other tissues of epoxy and hydroxy fatty acid accumulating plants |
Q38801581 | DGAT2 Mutation in a Family with Autosomal-Dominant Early-Onset Axonal Charcot-Marie-Tooth Disease |
Q38872155 | Dataset of the human homologues and orthologues of lipid-metabolic genes identified as DAF-16 targets their roles in lipid and energy metabolism |
Q51375339 | Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. |
Q36042028 | Detection of differentially expressed candidate genes for a fatty liver QTL on mouse chromosome 12. |
Q46175556 | Development of an ichthyosiform phenotype in Alox12b-deficient mouse skin transplants |
Q39786327 | Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors |
Q37416903 | Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues |
Q37227155 | Developmental regulation of diacylglycerol acyltransferase family gene expression in tung tree tissues. |
Q51116597 | Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat. |
Q39322543 | Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells |
Q38731637 | Diacylglycerol acyltransferase 2 links glucose utilization to fatty acid oxidation in the brown adipocytes |
Q38962260 | Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis |
Q37724007 | Dictyostelium discoideum Dgat2 can substitute for the essential function of Dgat1 in triglyceride production but not in ether lipid synthesis |
Q50952043 | Dietary Omega-3 Fatty Acids Prevented Adipocyte Hypertrophy by Downregulating DGAT-2 and FABP-4 in a Sex-Dependent Fashion. |
Q37096383 | Diurnal variations in myocardial metabolism |
Q28593436 | Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation |
Q91749616 | Dynamic characteristics of lipid metabolism in cultured granulosa cells from geese follicles at different developmental stages |
Q37230403 | Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers |
Q36284150 | Effect of 50 Hz electric field in diacylglycerol acyltransferase mRNA expression level and plasma concentration of triacylglycerol, free fatty acid, phospholipid and total cholesterol. |
Q85526475 | Effect of cholesterol on lipogenesis and VLDL-TG assembly and secretion in goose primary hepatocytes |
Q35001851 | Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin. |
Q35432791 | Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug |
Q42321933 | Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1 |
Q34521411 | Emerging roles of the myocardin family of proteins in lipid and glucose metabolism |
Q33716933 | Epidermal surface lipids |
Q33976390 | Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity |
Q93106586 | Evolution, dynamic expression changes and regulatory characteristics of gene families involved in the glycerophosphate pathway of triglyceride synthesis in chicken (Gallus gallus) |
Q34024580 | Evolutionary view of acyl-CoA diacylglycerol acyltransferase (DGAT), a key enzyme in neutral lipid biosynthesis. |
Q35663921 | Exploring Differentially Expressed Genes and Natural Antisense Transcripts in Sheep (Ovis aries) Skin with Different Wool Fiber Diameters by Digital Gene Expression Profiling |
Q54343693 | Expression and purification of recombinant tung tree diacylglycerol acyltransferase 2. |
Q34188011 | Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis |
Q38334129 | Expression of DGAT2 in white adipose tissue is regulated by central leptin action |
Q36174116 | Expression of Soluble Forms of Yeast Diacylglycerol Acyltransferase 2 That Integrate a Broad Range of Saturated Fatty Acids in Triacylglycerols |
Q33957237 | Expression of tung tree diacylglycerol acyltransferase 1 in E. coli. |
Q46170479 | Expression of two human acyl-CoA:diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes |
Q37892924 | Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease. |
Q90100887 | Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols |
Q54645548 | Follicle-stimulating hormone increases the intramuscular fat content and expression of lipid biosynthesis genes in chicken breast muscle*. |
Q35129155 | Function and localization of the Arabidopsis thaliana diacylglycerol acyltransferase DGAT2 expressed in yeast |
Q49907235 | Functional analysis of diacylglycerol O-acyl transferase 2 gene to decipher its role in virulence of Botrytis cinerea |
Q27938569 | Functional and topological analysis of yeast acyl-CoA:diacylglycerol acyltransferase 2, an endoplasmic reticulum enzyme essential for triacylglycerol biosynthesis |
Q31116096 | Functional annotation of genomic data with metabolic inference. |
Q61451411 | Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1 |
Q33867059 | Genetic control of de novo lipogenesis: role in diet-induced obesity |
Q51119200 | Genetic interaction of DGAT2 and FAAH in the development of human obesity. |
Q37257483 | Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation |
Q39762596 | Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). |
Q35870227 | Gut triglyceride production |
Q37092932 | HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy. |
Q38089264 | Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia |
Q91966496 | Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice |
Q34287889 | High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity |
Q36389644 | Host lipid droplets: An important source of lipids salvaged by the intracellular parasite Toxoplasma gondii. |
Q39392563 | How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage |
Q38832781 | Identification of DGAT2 Inhibitors Using Mass Spectrometry |
Q60044615 | Identification of the major diacylglycerol acyltransferase mRNA in mouse adipocytes and macrophages |
Q28118125 | Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily |
Q24303914 | Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities |
Q42819132 | Imaging of lipid biosynthesis: how a neutral lipid enters lipid droplets |
Q33898272 | Inactivation of human DGAT2 by oxidative stress on cysteine residues |
Q38258625 | Inborn errors of cytoplasmic triglyceride metabolism. |
Q39541130 | Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis |
Q41283943 | Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice |
Q40970388 | Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats. |
Q46410701 | Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. |
Q35922459 | Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin). |
Q37658846 | Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents |
Q36044983 | Integrated Analysis of the Roles of Long Noncoding RNA and Coding RNA Expression in Sheep (Ovis aries) Skin during Initiation of Secondary Hair Follicle |
Q92180471 | Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits |
Q36302747 | Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying |
Q35030629 | Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage |
Q27023275 | Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism |
Q33902090 | Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice |
Q28545014 | Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice |
Q38927251 | Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β. |
Q39718878 | Knockdown of triglyceride synthesis does not enhance palmitate lipotoxicity or prevent oleate-mediated rescue in rat hepatocytes |
Q35571228 | Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. |
Q38080471 | Latest research and development trends in non-insulin anti-diabetics |
Q47972230 | Lipid Droplet Biogenesis. |
Q37583253 | Lipid disequilibrium disrupts ER proteostasis by impairing ERAD substrate glycan trimming and dislocation |
Q27021518 | Lipid droplet biogenesis |
Q36145193 | Lipid droplet formation on opposing sides of the endoplasmic reticulum |
Q35852304 | Lipid metabolic enzymes: emerging drug targets for the treatment of obesity |
Q39536421 | Lipin-1 expression is critical for keratinocyte differentiation |
Q37258017 | Lipolysis and the integrated physiology of lipid energy metabolism |
Q50026330 | Liraglutide protects cardiac function in diabetic rats through the PPARα pathway |
Q35729216 | Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death |
Q42343443 | MOGAT2: A New Therapeutic Target for Metabolic Syndrome |
Q35235426 | Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling |
Q35752505 | Medical sequencing at the extremes of human body mass |
Q46258698 | Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. |
Q28510337 | Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition |
Q28743135 | Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform |
Q35685717 | Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice |
Q89944024 | Modulation of Fatty Acid-Related Genes in the Response of H9c2 Cardiac Cells to Palmitate and n-3 Polyunsaturated Fatty Acids |
Q36452544 | Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome |
Q35845468 | Molecular Characterization of the Elaeis guineensis Medium-Chain Fatty Acid Diacylglycerol Acyltransferase DGAT1-1 by Heterologous Expression in Yarrowia lipolytica |
Q24336781 | Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis |
Q37171127 | Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy |
Q33675926 | Monoacylglycerol acyltransferase-2 is a tetrameric enzyme that selectively heterodimerizes with diacylglycerol acyltransferase-1. |
Q26314642 | Monoacylglycerol and diacylglycerol acyltransferases and the synthesis of neutral glycerides in Manduca sexta |
Q28594324 | Murine diacylglycerol acyltransferase-2 (DGAT2) can catalyze triacylglycerol synthesis and promote lipid droplet formation independent of its localization to the endoplasmic reticulum |
Q33283626 | Mutation screen and association studies in the diacylglycerol O-acyltransferase homolog 2 gene (DGAT2), a positional candidate gene for early onset obesity on chromosome 11q13. |
Q36254134 | Mycobacterium marinum Degrades Both Triacylglycerols and Phospholipids from Its Dictyostelium Host to Synthesise Its Own Triacylglycerols and Generate Lipid Inclusions |
Q38025774 | Myocardial triacylglycerol metabolism. |
Q53469081 | Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. |
Q96585240 | Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial |
Q28392304 | Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis |
Q47282579 | Overexpression of diacylglycerol acyltransferase in Yarrowia lipolytica affects lipid body size, number and distribution |
Q24301076 | Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells |
Q28580665 | Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes |
Q51047219 | Overexpression of the active diacylglycerol acyltransferase variant transforms Saccharomyces cerevisiae into an oleaginous yeast. |
Q37632020 | PNPLA1 Deficiency in Mice and Humans Leads to a Defect in the Synthesis of Omega-O-Acylceramides. |
Q41898000 | PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide. |
Q37729861 | Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice |
Q54775599 | Phospholipid:diacylglycerol acyltransferase-mediated triacylglycerol biosynthesis is crucial for protection against fatty acid-induced cell death in growing tissues of Arabidopsis. |
Q46358588 | Polymorphisms of diacylglycerol acyltransferase 2 gene and their relationship with growth traits in goats |
Q36063586 | Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction |
Q45069919 | Preclinical pharmacokinetic characterization of 2-(4-(4-(5-(2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamido)-1H-benzo[d]imidazol-2-yl)phenyl)cyclohexyl) acetic acid, a novel DGAT-1 inhibitor |
Q88873924 | Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages |
Q41785858 | Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance |
Q34601279 | Protective Effects of Oleic Acid Against Palmitic Acid-Induced Apoptosis in Pancreatic AR42J Cells and Its Mechanisms |
Q38815860 | Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes |
Q37865348 | Recent insights into the structure and function of comparative gene identification-58. |
Q38995770 | Regulation of diacylglycerol acyltransferase 2 protein stability by gp78-associated endoplasmic-reticulum-associated degradation |
Q28507784 | Regulation of hepatic lipogenesis by the transcription factor XBP1 |
Q89519102 | Regulation of intestinal lipid metabolism: current concepts and relevance to disease |
Q36649458 | Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT". |
Q42183407 | Reorganization of cellular retinol-binding protein type 1 and lecithin:retinol acyltransferase during retinyl ester biosynthesis |
Q24642158 | Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 |
Q27342065 | Retracted: Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005 |
Q37892920 | Role of fatty acid transporters in epidermis: Implications for health and disease |
Q36660888 | Role of the gut in lipid homeostasis |
Q35192357 | Role of the gut in modulating lipoprotein metabolism. |
Q109374826 | SARS-CoV-2 exploits host DGAT and ADRP for efficient replication |
Q33813669 | Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats |
Q57922270 | Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications |
Q34628676 | Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis |
Q42500384 | Skin Barrier Development Depends on CGI-58 Protein Expression during Late-Stage Keratinocyte Differentiation |
Q88342687 | Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids |
Q64949842 | Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile. |
Q93181023 | Sodium hydrosulphide restores tumour necrosis factor-α-induced mitochondrial dysfunction and metabolic dysregulation in HL-1 cells |
Q33933844 | Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development |
Q95320630 | Structure and catalytic mechanism of a human triacylglycerol-synthesis enzyme |
Q33967299 | Structure-function analysis of diacylglycerol acyltransferase sequences from 70 organisms |
Q41818160 | Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases |
Q51548175 | Surface plasmon resonance analysis of interactions between diacylglycerol acyltransferase and its interacting molecules. |
Q46639276 | Targeted intestinal overexpression of the immediate early gene tis7 in transgenic mice increases triglyceride absorption and adiposity |
Q59049645 | Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver Disease |
Q47351487 | Targeting energy expenditure via fuel switching and beyond |
Q36246806 | The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model |
Q28505730 | The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4 |
Q96609644 | The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease |
Q55192060 | The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function. |
Q36213891 | The acyl-CoA binding protein is required for normal epidermal barrier function in mice |
Q28833221 | The biogenesis of chylomicrons |
Q36085605 | The cornified envelope: a model of cell death in the skin |
Q36364289 | The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease. |
Q34438156 | The emerging field of lipidomics |
Q28509052 | The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria |
Q35050718 | The expression and regulation of enzymes mediating the biosynthesis of triglycerides and phospholipids in keratinocytes/epidermis |
Q37264190 | The genetics of neutral lipid biosynthesis: an evolutionary perspective |
Q36807635 | The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation |
Q35050713 | The role of fatty acid elongation in epidermal structure and function |
Q92765422 | The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes |
Q37766367 | The twists and turns of sphingolipid pathway in glucose regulation |
Q35958448 | The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2 |
Q34817393 | Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis |
Q34687966 | Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis |
Q38222366 | Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors |
Q28730091 | Three acyltransferases and nitrogen-responsive regulator are implicated in nitrogen starvation-induced triacylglycerol accumulation in Chlamydomonas |
Q64245987 | Tissue Expression and Variation of the Gene and Its Effect on Carcass and Meat Quality Traits in Yak |
Q39650767 | Topological Orientation of Acyl-CoA:Diacylglycerol Acyltransferase-1 (DGAT1) and Identification of a Putative Active Site Histidine and the Role of the N Terminus in Dimer/Tetramer Formation |
Q92643515 | Treatment of human skeletal muscle cells with inhibitors of diacylglycerol acyltransferases 1 and 2 to explore isozyme-specific roles on lipid metabolism |
Q43051400 | Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor - WO2009126624. |
Q47719467 | Triglyceride Metabolism in the Liver. |
Q38646478 | Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis. |
Q39516919 | Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis |
Q41849112 | Unravelling hair follicle-adipocyte communication |
Q35785726 | Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. |
Q30402413 | Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol |
Q54336302 | α-lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects. |
Search more.